Patel S, Santani D (2009) Role of NF-kappa B in the pathogenesis of diabetes and its associated complications
Like other gastrointestinal effects of GLP-1 drugs, sulfur burps tend to be loudest early in treatment and in the days after each dose increase, then ease as the gut adapts
6(1)(c) GDPR) Certain personal data is processed in order to comply with legal or regulatory obligations imposed on Vision Healthcare, including accounting and tax obligations, administrative obligations, and statutory retention obligations
Tapering Considerations: Gradually reduce GLP-1 dosing while increasing fiber and protein intake Begin nutraceutical support (e.g., berberine, chromium) 24 weeks prior to taper Monitor lean mass and glycemic variability Support appetite signaling with mindful eating and circadian regulation Address gut motility and emotional eating patterns with botanical support Clinical Example: A Case in Practice A 52-year-old female on semaglutide for 6 months presented with nausea, fatigue, and concern about lean mass loss
Long-term outcomes after bariatric surgery: A systematic review and metaanalysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding
